Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,569
Closed -$291K 317
2024
Q2
$291K Buy
2,569
+236
+10% +$29.8K 0.09% 228
2024
Q1
$294K Buy
+2,333
New +$293K 0.11% 203
2023
Q3
Sell
-2,232
Closed -$287K 136
2023
Q2
$287K Buy
2,232
+225
+11% +$27.2K 0.12% 182
2023
Q1
$233K Buy
2,007
+193
+11% +$21.6K 0.18% 121
2022
Q4
$205K Buy
+1,814
New +$199K 0.17% 119

Other funds holding DXCM

TFB Advisors's DXCM Position: Q3 2024 in Review

TFB Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,569 shares — an estimated $291K sold.

TFB Advisors first reported a position in DXCM in Q4 2022 and held it in 5 quarters. The position peaked at $294K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • TFB Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • TFB Advisors sold 2,569 DexCom shares in Q3 2024, an estimated $291K.
  • TFB Advisors first reported a position in DexCom in Q4 2022 and held it in 5 quarters.
  • TFB Advisors's DexCom position peaked at $294K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on TFB Advisors's 13F filing for Q3 2024, filed 31 Oct 2024.